ジェイファーマ株式会社
Tokyo, JP · 6 known investors
J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases. The Tokyo-based biotech develops innovative small-molecule drugs and is listed on the Tokyo Stock Exchange Growth Market.
Founders & leadership
�益
𠮷武 益広代表取締役社長 (Representative Director & President)
藤裕
藤本 裕取締役CFO
山寛
山本 寛取締役CBO
Investors · 6
Competitors · 2
by search overlapJohnson & Johnson12 shared keywordsJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with ジェイファーマ株式会社 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does ジェイファーマ株式会社 do?
- J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases. The Tokyo-based biotech develops innovative small-molecule drugs and is listed on the Tokyo Stock Exchange Growth Market.
- Who founded ジェイファーマ株式会社?
- ジェイファーマ株式会社 was founded by 𠮷武 益広.
- Who are ジェイファーマ株式会社's investors?
- ジェイファーマ株式会社's investors include F-Prime Capital, Newton Biocapital, Oita Venture Capital, OSAKA University Venture Capital, Seibu Shinkin Capital, UntroD Capital.
- Where is ジェイファーマ株式会社 headquartered?
- ジェイファーマ株式会社 is headquartered in Tokyo, JP.